ABCG2 and breast cancer: However, studies conducted on MCF-7 mitoxantrone-resistant sublines of breast cancer cells, in the absence of the overexpression of known multidrug resistance transporters, revealed a new ATP-dependent pump of anthracycline anticancer drugs named breast cancer resistance protein (BCRP)—now known as ABCG2 [24,25,26].